Evidence map›Paper›PMID 28848664›Full record

ReviewESMO open2016

The European Cancer Patient's Bill of Rights, update and implementation 2016.

Mark Lawler, Ian Banks, Kate Law, Tit Albreht, Jean-Pierre Armand, Mariano Barbacid, Michèle Barzach, Jonas Bergh, David Cameron, Pierfranco Conte and 50 more

Abstract readReview
In one paragraph

Review in ESMO open, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. The requirements of a specialist breast centre.Breast (Edinburgh, Scotland) · 2020
    Guideline
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

60 authors.

Mark LawlerQueen's University Belfast,; European Cancer Concord.
Ian BanksEuropean Cancer Concord,; European Men's Health Forum,; University of Leeds.
Kate LawEuropean Cancer Concord.
Tit AlbrehtInstitut za varovanje zdravja Republike Slovenija.
Jean-Pierre ArmandGustave Roussy.
Mariano BarbacidExperimental Oncology, Molecular Oncology Programme, Centro Nacional de Investigaciones Oncológicas (CNIO).
Michèle BarzachIHU Strasbourg Board of Trustees.
Jonas BerghDepartment of Oncology-Pathology, Karolinska Institutet.
David CameronEdinburgh Cancer Centre, University of Edinburgh.
Pierfranco ConteIstituto Oncologico Veneto.
Filippo de BraudMedical Oncology Division, National Cancer Institute.
Aimery de GramontDepartment of Oncology, Institut Hospitalier Franco-Britannique.
Francesco De LorenzoItalian Federation of Volunteer-based Cancer Organizations,; European Cancer Patient Coalition.
Volker DiehlInternal Medicine, Universitat zu Koln.
Sarper DilerMyeloma Patients Europe.
Sema ErdemEuropa Donna.
Jan GeisslerLeukemia Patient Advocates Foundation,; European Patients Academy on Therapeutic Innovation.
Jola Gore-BoothEuropaColon.
Geoffrey HenningEuropaColon.
Liselotte HøjgaardDanmarks Grundforskningsfond,; Faculty of Health and Medical Sciences, Kobenhavns Universitet.
Denis HorganEuropean Alliance for Personalised Medicine.
Jacek JassemDepartment of Oncology and Radiotherapy, Medical University of Gdansk.
Peter JohnsonDepartment of Medical Oncology, University of Southampton,; Cancer Research UK.
Stein KaasaInstitute of Cancer Research and Molecular Medicine, Norges teknisk-naturvitenskapelige universitet.
Peter KapiteinInspire2Live.
Sakari KarjalainenSyopajarjestot,; Association of European Cancer Leagues.
Joan KellyAssociation of European Cancer Leagues,; Irish Cancer Society.
Anita KienesbergerAustrian Childhood Cancer Organisation.
Carlo La VecchiaDepartment of Clinical Sciences and Community Health, Universita degli Studi di Milano.
Denis LacombeEuropean Organisation for Research and Treatment of Cancer.
Tomas LindahlFrancis Crick Institute.
Bob LöwenbergDepartment of Hematology, Erasmus University Medical Center.
Lucio LuzzattoMuhimbili University of Health and Allied Sciences,; Universita degli Studi di Firenze.
Rebecca MalbySchool of Health and Social Care, London South Bank University.
Ken MastrisEuropa Uomo.
Françoise MeunierEuropean Organisation for Research and Treatment of Cancer.
Martin MurphyEuropean Cancer Concord, Society for Translational Oncology.
Peter NarediGoteborgs Universitet,; European Cancer Organisation.
Paul NurseFrancis Crick Institute.
Kathy OliverInternational Brain Tumour Alliance.
Jonathan PearceLymphoma Association.
Jana PelouchovEuropean Cancer Patient Coalition.
Martine PiccartInstitut Jules Bordet.
Bob PinedoVuMC Cancer Center.
Gilly Spurrier-BernardMelanoma Patient Network Europe.
Richard SullivanInstitute of Cancer Policy, Kings Health Partners Integrated Cancer Centre.
Josep TaberneroVall d'Hebron University Hospital and Institute of Oncology (VHIO), Universitat Autònoma de Barcelona.
Cornelis Van de VeldeDepartment of Surgery, Leids Universitair Medisch Centrum.
Bert van HerkEuropean Cancer Organisation,; Spaarne Gasthuis.
Peter VedstedInstitute for Public Health and Department of Clinical Medicine, Aarhus Universitet.
Anita WaldmannLeukaemiehilfe RHEIN-MAIN.
David WellerCentre for Population Health Sciences, University of Edinburgh.
Nils WilkingDepartment of Oncology, Karolinska Institutet,; Skåne University Hospital.
Roger WilsonSarcoma Patients EuroNet EV.
Wendy YaredAssociation of European Cancer Leagues.
Christoph ZielinskiComprehensive Cancer Center and Department of Medicine I, Medical University of Vienna,; European Society for Medical Oncology.
Harald Zur HausenGerman Cancer Research Centre, University of Heidelberg.
Thierry Le ChevalierEuropean Cancer Concord,; Institute Gustave Roussy.
Patrick JohnstonQueen's University Belfast,; European Cancer Concord.
Peter SelbyEuropean Cancer Concord,; University of Leeds,. Electronic address: P.J.Selby@leeds.ac.uk.

Funding

Department of Health RP-PG-0707-10101
6 · The paper itself

Abstract

In this implementation phase of the European Cancer Patient's Bill of Rights (BoR), we confirm the following three patient-centred principles that underpin this initiative:The right of every European citizen to receive the most accurate information and to be proactively involved in his/her care.The right of every European citizen to optimal and timely access to a diagnosis and to appropriate specialised care, underpinned by research and innovation.The right of every European citizen to receive care in health systems that ensure the best possible cancer prevention, the earliest possible diagnosis of their cancer, improved outcomes, patient rehabilitation, best quality of life and affordable health care. The key aspects of working towards implementing the BoR are:Agree our high-level goal. The vision of 70% long-term survival for patients with cancer in 2035, promoting cancer prevention and cancer control and the associated progress in ensuring good patient experience and quality of life.Establish the major mechanisms to underpin its delivery. (1) The systematic and rigorous sharing of best practice between and across European cancer healthcare systems and (2) the active promotion of Research and Innovation focused on improving outcomes; (3) Improving access to new and established cancer care by sharing best practice in the development, approval, procurement and reimbursement of cancer diagnostic tests and treatments.Work with other organisations to bring into being a Europe based centre that will (1) systematically identify, evaluate and validate and disseminate best practice in cancer management for the different countries and regions and (2) promote Research and Innovation and its translation to maximise its impact to improve outcomes.

Indexed as

Bill of RightsCancer ConcordCancer outcomes

Identifiers

PMID28848664
PMCPMC5548978

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.